Triage Survey for Infectious Disease Eligibility

Part of paid clinical trials in Brooklyn, New York.

Sponsor
Brooklyn Clinical Research
Study ID
NCT06492187
Status
Recruiting
Apply to this trial

Conditions

  • HIV-1-infection
  • Infectious Disease
  • Vaccination; Infection

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

SWIFT-ID-101 is a single site survey study designed to assess potential participants' eligibility to screen for industry-sponsored clinical trials for diagnosis, treatment, or prevention of infectious diseases such as in the areas of HIV, vaccines, and other infectious-diseases areas. A physician will oversee the informed consent process, after which participants will be surveyed on demographics, medical/surgical history, physical examination, comorbidities, and any current symptoms. Informed consent will be done electronically (preferable) or on paper. Informed consent may be done in-person or remotely, depending on patient preference. Information related to HIV, hepatitis B and C, other infectious diseases, or substance use disorder will also be obtained if applicable. Site staff may collect vital signs, fingerpick testing, urine drug screens, blood draws, EKG, and pregnancy tests. Some testing may be recommended in a fasting condition. A doctor will review medical history and results of the above evaluations with the participant to determine study suitability via clinical interview. The doctor may reach out to the patient's current treating physicians, other providers, and pharmacies to determine eligibility for clinical trials. A follow-up phone call may be needed to discuss testing results and/or trial eligibility. If a participant is deemed eligible for future trials and if the participant remains interested, counseling on contraception requirements for trials will be discussed.

Key Dates

Start date
Jun 28, 2024
Status verified
Jul 2024
Primary completion
Jan 28, 2029
Completion
Jan 28, 2029

Study Design

Enrollment
10,000 participants (estimated)

Primary Outcome Measure

Number of participants interested in clinical research [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Brooklyn Clinical ResearchBrooklynNew York11226
Ammara Mushtaq, MD
[email protected]
929-203-5879
Katherine Azer, MS
[email protected]
9293327848
Ammara Mushtaq, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Brooklyn, NY

By research site
Brooklyn Clinical Research· Brooklyn, NY

Related Studies